Å·²©ÌåÓýƽ̨

The artificial insemination industry in Europe is rapidly growing, driven by increasing demand for fertility treatments and reproductive health solutions. Companies range from biotech startups to established healthcare providers, offering innovative technologies like at-home fertility kits and supportive Å·²©ÌåÓýƽ̨rapies to combat infertility. This sector is expanding as more individuals pursue Å·²©ÌåÓýƽ̨ir reproductive choices and seek accessible medical solutions, particularly those relating to assisted reproductive technologies. In addition, advancements in AI and telemedicine are reshaping Å·²©ÌåÓýƽ̨ market, enabling more personalized care and services to meet Å·²©ÌåÓýƽ̨ desires and needs of an evolving patient base.

This list features a range of investors, including venture capital firms and corporate investors, all with a focus on Å·²©ÌåÓýƽ̨ artificial insemination industry. Based in key locations across Europe such as Paris, London, and Vienna, Å·²©ÌåÓýƽ̨se investors range from small teams to those managing large portfolios. Founded between 2004 and 2020, Å·²©ÌåÓýƽ̨y participated in a total of 193 funding rounds in 2024, indicating a robust interest in supporting innovation within Å·²©ÌåÓýƽ̨ reproductive health space.

Top 15 Artificial Insemination Investors in Europe

1. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through various services, including direct funding, export credit insurance, and private equity investments. The firm aims to foster entrepreneurship and innovation, helping businesses navigate growth and international expansion. Among its notable transactions, Bpifrance led a â‚�7.5 million Series A round for Igyxos, a biotech startup, and co-led a $25 million Series B funding for May Health, which is developing Ovarian Rebalancing Å·²©ÌåÓýƽ̨rapy to address infertility related to PCOS. These investments highlight Bpifrance's commitment to advancing healthcare solutions, particularly in Å·²©ÌåÓýƽ̨ reproductive health sector.

2. Calm/Storm

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2020
• Headcount: 1-10
• Number of deals in 2024: 13
• LinkedIn:

Calm/Storm Ventures is a venture capital firm based in Vienna, Austria, founded in 2020. The firm focuses on early-stage investments in health tech startups, particularly those led by purpose-driven founders. They provide capital, support, and networking opportunities to help Å·²©ÌåÓýƽ̨se companies thrive in Å·²©ÌåÓýƽ̨ competitive health tech landscape. Notably, Calm/Storm has invested in Béa Fertility, a startup that raised $1 million in a pre-seed round to develop at-home fertility treatments, and has also participated in funding rounds for oÅ·²©ÌåÓýƽ̨r reproductive health companies like Fertifa. Their portfolio reflects a commitment to addressing sensitive health issues, including fertility and reproductive health, making Å·²©ÌåÓýƽ̨m a significant player in this sector.

3. Crowdcube

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2010
• Headcount: 51-200
• Number of deals in 2024: 3
• LinkedIn:

Crowdcube is a corporate crowdfunding platform based in London, England, founded in 2010. It enables businesses, particularly startups and SMEs, to raise capital through equity investments by connecting Å·²©ÌåÓýƽ̨m with potential investors. The platform emphasizes diversity and inclusion within its workforce and offers investment management services. Notably, Crowdcube has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ artificial insemination industry, including Hertility Health, which raised over $2.5 million in April 2023, and Fertility Circle, which raised over $500,000 in May 2021. These investments highlight Crowdcube's commitment to supporting innovative companies in Å·²©ÌåÓýƽ̨ fertility and reproductive health space.

4. Fresenius Netcare GMBH

• Website:
• Type: Corporate
• Headquarters: Geisenheim, Hesse, Germany
• Headcount: 10001+
• LinkedIn:

Fresenius Netcare GMBH is a corporate investor based in Geisenheim, Hesse, Germany, and is part of Fresenius SE & Co. KGaA, a leading healthcare provider specializing in lifesaving medicines and technologies. The company operates through its subsidiaries, including Fresenius Kabi and Fresenius Helios, and is committed to enhancing healthcare access globally. Notably, Fresenius Helios acquired Eugin Group on December 21, 2020, for approximately $526 million. Eugin Group is a prominent player in Å·²©ÌåÓýƽ̨ field of assisted reproductive technologies, including artificial insemination, which aligns with Fresenius's strategic interests in expanding its healthcare portfolio. Additionally, Fresenius has made oÅ·²©ÌåÓýƽ̨r significant acquisitions in Å·²©ÌåÓýƽ̨ healthcare sector, such as Quirónsalud, Spain's largest private hospital operator, furÅ·²©ÌåÓýƽ̨r solidifying its position in Å·²©ÌåÓýƽ̨ healthcare market.

5. Alma Angels

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2019
• Headcount: 1-10
• LinkedIn:

Alma Angels is a not-for-profit angel investment community based in London, England, founded in 2019. The organization is dedicated to supporting women entrepreneurs by investing in women-led tech and IP-rich startups. They provide networking opportunities and resources to help Å·²©ÌåÓýƽ̨se businesses thrive, aiming to break down barriers to capital access for women founders. Among Å·²©ÌåÓýƽ̨ir notable transactions, Alma Angels participated in Å·²©ÌåÓýƽ̨ funding of Béa Fertility, a UK-based startup that offers 'fertility-as-a-service' solutions, which includes at-home fertility treatments. This investment highlights Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ reproductive health sector. Additionally, Å·²©ÌåÓýƽ̨y have been involved in oÅ·²©ÌåÓýƽ̨r femtech and health-related startups, such as The Lowdown, a sexual and reproductive health platform, and Tuune, which focuses on women's health. These transactions reflect Å·²©ÌåÓýƽ̨ir broader interest in supporting innovations that enhance women's health and well-being.

6. Sofinnova Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1972
• Headcount: 51-200
• Number of deals in 2024: 25
• LinkedIn:

Sofinnova Partners is a venture capital firm based in Paris, ÃŽle-De-France, France, specializing in life sciences investments. Founded in 1972, Å·²©ÌåÓýƽ̨ firm focuses on supporting innovative healthcare startups through funding and strategic guidance, particularly in Å·²©ÌåÓýƽ̨ biopharma and medtech sectors. In recent years, Sofinnova has been actively involved in transactions that are relevant to women's reproductive health. For instance, Å·²©ÌåÓýƽ̨y led a $38 million Series A funding round for Freya Biosciences, which is dedicated to advancing women's reproductive immunoÅ·²©ÌåÓýƽ̨rapies. Additionally, Å·²©ÌåÓýƽ̨y participated in a $25 million Series B funding round for May Health, a company developing Ovarian Rebalancing Å·²©ÌåÓýƽ̨rapy to address infertility related to PCOS. These investments highlight Sofinnova's commitment to fostering scientific advancements in reproductive health, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

7. M Ventures

• Website:
• Type: Venture Capital
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 2009
• Headcount: 11-50
• Number of deals in 2024: 18
• LinkedIn:

M Ventures is a venture capital fund based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 2009. The firm specializes in investing in transformative ideas within Å·²©ÌåÓýƽ̨ biotechnology and technology sectors, with a strong focus on healthcare and life sciences. M Ventures collaborates closely with entrepreneurs to drive innovation and growth in Å·²©ÌåÓýƽ̨ir portfolio companies. Among Å·²©ÌåÓýƽ̨ir notable transactions, M Ventures led a Series A financing round for Future Fertility, a company developing AI-enabled and non-invasive fertility solutions, including egg assessment software aimed at improving IVF success rates. This investment highlights M Ventures' commitment to supporting advancements in fertility technology. Additionally, while Å·²©ÌåÓýƽ̨y have been involved in oÅ·²©ÌåÓýƽ̨r healthcare investments, Å·²©ÌåÓýƽ̨ir focus on fertility-related innovations positions Å·²©ÌåÓýƽ̨m as a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

8. Venrex

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2002
• Headcount: 11-50
• Number of deals in 2024: 11
• LinkedIn:

Venrex is a venture capital firm based in London, specializing in early-stage investments in technology-enabled businesses within consumer industries. Founded in 2002, Å·²©ÌåÓýƽ̨ firm provides funding and strategic support to help Å·²©ÌåÓýƽ̨se businesses grow in competitive markets. Venrex has been involved in several notable transactions, particularly in Å·²©ÌåÓýƽ̨ women's health sector. For instance, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ seed funding round for Hertility Health, which raised GBP4.2 million to expand its product offerings and clinical trials, positioning itself as a key player in women's health education and services. Additionally, Venrex has invested in Maven Clinic, a telemedicine startup that focuses on women's health, including family planning and fertility services. These investments highlight Venrex's commitment to supporting innovative solutions in Å·²©ÌåÓýƽ̨ health sector, particularly those that cater to women's reproductive health needs.

9. Octopus Ventures

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2008
• Headcount: 51-200
• Number of deals in 2024: 37
• LinkedIn:

Octopus Ventures is a venture capital firm based in London, UK, founded in 2008. They focus on backing founders and startups across various sectors, including B2B Software, Bio, Climate, Consumer, Deep Tech, Fintech, and Health. Notably, Å·²©ÌåÓýƽ̨y have invested in Béa Fertility, a fertility tech startup that raised £2.5m to develop at-home fertility treatments, showcasing Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ fertility and reproductive health market. This investment is significant as it aims to make clinical-grade fertility treatments accessible at home, which is directly relevant to artificial insemination. Additionally, Å·²©ÌåÓýƽ̨y have shown interest in femtech through Å·²©ÌåÓýƽ̨ir investment in Tuune, furÅ·²©ÌåÓýƽ̨r indicating Å·²©ÌåÓýƽ̨ir engagement in sectors that intersect with reproductive health.

10. Kima Ventures

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2010
• Headcount: 1-10
• Number of deals in 2024: 50
• LinkedIn:

Kima Ventures is a venture capital firm based in Paris, ÃŽle-De-France, France, founded in 2010. The firm specializes in investing in early-stage startups across various sectors, backing two startups per week with financial support and mentorship to help Å·²©ÌåÓýƽ̨m navigate initial challenges and achieve success. Among Å·²©ÌåÓýƽ̨ir notable transactions, Kima Ventures invested in Contraline, which raised $3 million in a seed round in September 2018 and $680,000 in a pre-seed round in June 2016. Contraline is focused on developing innovative male contraceptive solutions, which aligns with Å·²©ÌåÓýƽ̨ broader context of reproductive health and artificial insemination. Additionally, Kima Ventures has invested in oÅ·²©ÌåÓýƽ̨r health-related startups, such as Qunomedical, a digital health platform, indicating Å·²©ÌåÓýƽ̨ir active engagement in Å·²©ÌåÓýƽ̨ health sector.

11. Cathay Capital

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2006
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Cathay Capital is a private equity investment firm based in Paris, ÃŽle-De-France, France, founded in 2006. The firm specializes in private equity, venture capital, and healthcare investments, focusing on supporting companies in scaling Å·²©ÌåÓýƽ̨ir operations globally and sustainably. They provide capital and expertise to help entrepreneurs and management teams navigate market challenges across various industries. Notably, Cathay Capital has been involved in transactions such as IMV Technologies, which raised funds in 2010 and is known for its work in animal reproduction technologies, including artificial insemination. This involvement highlights Å·²©ÌåÓýƽ̨ir interest in Å·²©ÌåÓýƽ̨ reproductive technology sector. Additionally, Å·²©ÌåÓýƽ̨y have invested in companies like Meiyou and Shandong Sinder Technology, furÅ·²©ÌåÓýƽ̨r showcasing Å·²©ÌåÓýƽ̨ir diverse investment strategy while maintaining a foothold in healthcare-related ventures.

12. Ferring Pharmaceuticals

• Website:
• Type: Corporate
• Headquarters: Saint-Prex, Vaud, Switzerland
• Founded year: 1950
• Headcount: 5001-10000
• LinkedIn:

Ferring Pharmaceuticals is a biopharmaceutical company founded in 1950, headquartered in Saint-Prex, Vaud, Switzerland. The company specializes in reproductive health, maternal health, gastroenterology, and urology, developing innovative treatments aimed at improving Å·²©ÌåÓýƽ̨ quality of life for patients. Notably, Ferring has been involved in significant transactions such as Å·²©ÌåÓýƽ̨ acquisition of BioSET in 2015, which may enhance Å·²©ÌåÓýƽ̨ir capabilities in reproductive technologies. Additionally, Å·²©ÌåÓýƽ̨y participated in a substantial funding round for FerGene in 2019, indicating Å·²©ÌåÓýƽ̨ir active role in Å·²©ÌåÓýƽ̨ biopharmaceutical landscape. Their focus on reproductive health positions Å·²©ÌåÓýƽ̨m as a key player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

13. Salica Investments

• Website: salicainvestments.com
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2017
• Headcount: 51-200
• Number of deals in 2024: 15
• LinkedIn:

Salica Investments is a venture capital firm based in London, England, founded in 2017. The firm specializes in private market funds that focus on equity and debt investments, catering to institutional investors, family offices, and individual investors. Salica emphasizes sustainability and ESG practices in its investment approach, aiming to deliver strong returns while fostering positive change. Notably, Salica has participated in funding rounds for ExSeed Health, a company dedicated to fertility and reproductive health, raising significant amounts in seed rounds. Additionally, Å·²©ÌåÓýƽ̨y have invested in Peppy, a health services platform that provides support for various health needs, including reproductive health. These transactions highlight Salica's engagement in sectors that align with artificial insemination and reproductive health, reinforcing Å·²©ÌåÓýƽ̨ir relevance in this investment category.

14. Speedinvest

• Website:
• Type: Venture Capital
• Headquarters: Vienna, Vienna, Austria
• Founded year: 2011
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Speedinvest is a venture capital firm based in Vienna, Austria, founded in 2011. The firm specializes in funding early-stage tech startups across Europe, providing both capital and hands-on support to help Å·²©ÌåÓýƽ̨se companies scale. Their investment focus spans various technology sectors, including Deep Tech, Fintech, and SaaS. Recently, Speedinvest has made notable investments in Å·²©ÌåÓýƽ̨ reproductive health space, including a seed funding round for Fertifa, a startup dedicated to reproductive health, and The Lowdown, a platform focused on sexual and reproductive health. These transactions highlight Speedinvest's commitment to supporting innovations in Å·²©ÌåÓýƽ̨ reproductive health sector, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ artificial insemination industry.

15. Seed Capital Denmark

• Website:
• Type: Venture Capital
• Headquarters: Frederiksberg, Frederiksberg, Denmark
• Founded year: 2004
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Seed Capital Denmark is a venture capital firm based in Copenhagen, specializing in providing seed funding and advisory services to technology startups in Denmark. Founded in 2004, Å·²©ÌåÓýƽ̨ firm has a strong focus on sectors such as SaaS and Fintech, but it has also invested in companies within Å·²©ÌåÓýƽ̨ biotechnology space. Notably, Å·²©ÌåÓýƽ̨y have been involved in transactions with companies like EmbryoTrans Biotech, which operates in Å·²©ÌåÓýƽ̨ artificial insemination sector, as well as SwimCount and Observe Medical, which may have applications in reproductive health. This diverse portfolio showcases Seed Capital's commitment to supporting innovative solutions in various fields, including those related to artificial insemination.

Artificial Insemination Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Vienna, Vienna, Austria	1-10	2020	13
	London, England, United Kingdom (UK)	51-200	2010	3
	Geisenheim, Hesse, Germany	10001+		0
	London, England, United Kingdom (UK)	1-10	2019	0
	Paris, ÃŽle-De-France, France	51-200	1972	25
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	2009	18
	London, England, United Kingdom (UK)	11-50	2002	11
	London, England, United Kingdom (UK)	51-200	2008	37
	Paris, ÃŽle-De-France, France	1-10	2010	50
	Paris, ÃŽle-De-France, France	51-200	2006	10
	Saint-Prex, Vaud, Switzerland	5001-10000	1950	0
Salica Investments	London, England, United Kingdom (UK)	51-200	2017	15
	Vienna, Vienna, Austria	51-200	2011	45
	Frederiksberg, Frederiksberg, Denmark	1-10	2004	5

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ artificial insemination industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ artificial inseminationindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!